The military said it would tighten its grip on the vital waterway until the U.S. ended its blockade of Iranian ports. The ...

Gilead Sciences' TROP2-targeting drug Trodelvy is already used as a third-line treatment for PD-L1-positive triple-negative breast cancer (TNBC), but could be heading for use in previously untreated ...

Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...

The diplomacy came as the White House dismissed reports that President Trump wanted to extend the cease-fire, while still ...